| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/1994 | EP0346500B1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/27/1994 | EP0191771B1 Automatic injector assembly |
| 07/27/1994 | CN1089951A Novel glycoforms of soluble complement receptor 1 |
| 07/27/1994 | CN1089950A Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| 07/27/1994 | CN1089779A Food composition |
| 07/27/1994 | CA2113868A1 Ultra-pure human interleukin-6 |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | US5332803 Solvent extraction from wheat, complexing with polysaccharide |
| 07/26/1994 | US5332802 Human collagen processing and autoimplant use |
| 07/26/1994 | US5332742 Ocular hypotensive |
| 07/26/1994 | US5332726 Antithrombotic peptides and pseudopeptides |
| 07/26/1994 | US5332672 Prevention of ES cell differentiation by ciliary neurotrophic factor |
| 07/26/1994 | US5332671 Production of vascular endothelial cell growth factor and DNA encoding same |
| 07/26/1994 | US5332670 Which binds only after activation of the resting platelets |
| 07/26/1994 | US5332669 Prostate-derived mitogen |
| 07/26/1994 | US5332664 Human calcitonin precursor polyprotein structural gene |
| 07/26/1994 | US5332582 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/26/1994 | US5332576 Local anesthetic, solvent, bioadhesive carrier |
| 07/26/1994 | US5332571 Products containing a lithium salt and a tumor necrosis factor |
| 07/26/1994 | CA2087739A1 Putative target for an immunotherapeutic approach to prevent, and stop the neurological and other symptoms of lesch-nyhan syndrome in humans: reconstructed cdna and protein antisense to the human hprt gene |
| 07/26/1994 | CA2087738A1 Potential target for an immunotherapeutic approach to stop huntington's chorea in humans: cdna and protein structures for an intracellular activator of the human glutamate receptor, brain lactate dehydrogenase and vacuolar atpase reconstructed from the antisense strand of baboon urate oxi dase gene |
| 07/26/1994 | CA1331074C Irreversible peptide ligands for bombesin receptors |
| 07/26/1994 | CA1330943C Growth inhibiting agent and the use thereof |
| 07/26/1994 | CA1330937C Hemoglobin multiple emulsion |
| 07/23/1994 | CA2113929A1 Therapeutic agent for niddm |
| 07/22/1994 | CA2113739A1 Human cancer inhibitory pentapeptide amides |
| 07/21/1994 | WO1994016328A1 Synthetic oligopeptides analogous to protein signal sequences methods of identification and methods of use |
| 07/21/1994 | WO1994016096A2 Method to predict active growth of bacteria adhered to a surface |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994016085A2 Hybrid proteins having cross-linking and tissue-binding activities |
| 07/21/1994 | WO1994016083A1 Cloning of enterokinase and method of use |
| 07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/21/1994 | WO1994016075A2 Process for producing m-csf 223 |
| 07/21/1994 | WO1994016074A2 High molecular weight b-cell growth factor: interleukin-14 |
| 07/21/1994 | WO1994016073A2 Methods and reagents for inhibiting furin endoprotease |
| 07/21/1994 | WO1994016072A1 Vectors useful for controlling hiv-1 replication and methods for using the same |
| 07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
| 07/21/1994 | WO1994016069A2 Ras associated gap proteins |
| 07/21/1994 | WO1994016068A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | WO1994016067A1 Serotoninergic receptors (5ht6 and 5ht7) and use thereof |
| 07/21/1994 | WO1994016066A1 Agents for the prevention and treatment of hiv replication and aids in humans |
| 07/21/1994 | WO1994016065A1 Producing cells for transplantation to reduce host rejection and resulting cells |
| 07/21/1994 | WO1994015969A1 Recombinant anti-hiv antibody and preparation thereof |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015962A2 Derivatized calcitonins |
| 07/21/1994 | WO1994015961A2 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | WO1994015960A1 Peptide with glutamate liberation inhibitor and calcium channel inhibitor activities |
| 07/21/1994 | WO1994015959A1 New peptides |
| 07/21/1994 | WO1994015958A2 Peptide inhibitors of cell adhesion |
| 07/21/1994 | WO1994015956A1 Endothelin converting enzyme inhibitors |
| 07/21/1994 | WO1994015955A1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 07/21/1994 | WO1994015954A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same |
| 07/21/1994 | WO1994015953A1 Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases |
| 07/21/1994 | WO1994015952A1 Method for production of a kappa-casein glycomacropeptide and use of a kappa-casein glycomacropeptide |
| 07/21/1994 | WO1994015950A1 Purification of immunoglobulin |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015915A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | WO1994015914A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | WO1994015909A1 Amino acids and peptides having modified terminals |
| 07/21/1994 | WO1994015908A1 Propionamide derivative and medicinal use thereof |
| 07/21/1994 | WO1994015906A1 Hiv protease inhibitors and their preparation |
| 07/21/1994 | WO1994015653A1 Tgf-beta formulation for inducing bone growth |
| 07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015640A1 Methods and compositions for the direct concentrated delivery of passive immunity |
| 07/21/1994 | WO1994015639A1 Methods for inducing long-term immunological non-responsiveness to allografts |
| 07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015634A1 Tat and rev oligopeptides in hiv treatment |
| 07/21/1994 | WO1994015633A1 ANTI-CANCER UTILITY OF hCG VACCINES |
| 07/21/1994 | WO1994015631A1 Dry plasminogen preparation |
| 07/21/1994 | WO1994015630A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/21/1994 | WO1994015629A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015621A1 Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
| 07/21/1994 | WO1994015618A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | WO1994015613A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 07/21/1994 | WO1994015608A1 Hiv protease inhibitors |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994015587A2 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
| 07/21/1994 | WO1994015584A1 Solution containing igf-1 |
| 07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | WO1994015578A1 Anticaries compositions |
| 07/21/1994 | WO1994012648A3 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | WO1994012625A3 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL β-BARREL |
| 07/21/1994 | WO1994012537A3 Granulocyte chemotactic protein |
| 07/21/1994 | WO1994012534A3 Melanogenic inhibitor, and methods of producing and using the same |
| 07/21/1994 | WO1994012170A3 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/21/1994 | WO1994012144A3 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 07/21/1994 | WO1994007527A3 Vasoactive peptide inhibition |
| 07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
| 07/21/1994 | DE4301452A1 New di:phenyl:acetyl-argininamide derivs. |
| 07/21/1994 | CA2153987A1 Amino acids and peptides having modified terminals |
| 07/21/1994 | CA2153781A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | CA2153777A1 Hiv protease inhibitors |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |